Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera
10:19am, Wednesday, 21'st Jun 2023
Catalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North America to Santhera's DMD treatment candidate, vamorolone, which is currently under FDA review.
Catalyst (CPRX) Is Considered a Good Investment by Brokers: Is That True?
10:58am, Monday, 19'th Jun 2023
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
The 7 Best Stocks Under $15 to Buy in June 2023
07:52pm, Thursday, 01'st Jun 2023
As a rule of thumb, you want to buy quality names in the market, which admittedly rules out several ideas for best stocks under $15 for June. It's not that cheap securities don't exist.
Wall Street Analysts See Catalyst (CPRX) as a Buy: Should You Invest?
10:34am, Thursday, 01'st Jun 2023
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Down 19% in 1 Day, Is Catalyst Pharmaceuticals a Smart Contrarian Buy?
08:15am, Monday, 22'nd May 2023
The market did not like the contents of Catalyst's latest earnings report. Overly-high expectations for its sales are to blame for its stock falling.
5 Stocks to Keep a Tab on for Solid Earnings Acceleration
08:23am, Monday, 15'th May 2023
Notable companies to have witnessed earnings acceleration as of now are Catalyst Pharmaceuticals (CPRX), Warby Parker (WRBY), MakeMyTrip (MMYT), Brookfield Renewable Partners (BEP) & Century Aluminum
Should You Invest in Catalyst (CPRX) Based on Bullish Wall Street Views?
10:39am, Friday, 12'th May 2023
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
3 Reasons Growth Investors Will Love Catalyst (CPRX)
02:26pm, Wednesday, 26'th Apr 2023
Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.
Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023
08:03am, Monday, 24'th Apr 2023
The Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET The Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET
Catalyst Pharmaceuticals: Fixing Its Misnomer Is No Easy Task
07:51am, Wednesday, 19'th Apr 2023
Catalyst Pharmaceuticals: Fixing Its Misnomer Is No Easy Task
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
12:00pm, Tuesday, 18'th Apr 2023
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
Catalyst (CPRX) Up 14.1% Since Last Earnings Report: Can It Continue?
12:55pm, Friday, 14'th Apr 2023
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Catalyst Pharmaceutical (CPRX) Flat As Market Sinks: What You Should Know
06:59pm, Wednesday, 12'th Apr 2023
Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $17.55, making no change from the previous trading session.
2 Top Growth Stocks That Can Withstand an Economic Downturn
10:15am, Wednesday, 05'th Apr 2023
New data points to a looming recession in the U.S. In response, growth stocks took a step backward yesterday. Eli Lilly and Catalyst Pharmaceuticals are both capable of swimming against the current.
1 Growth Stock to Buy Before the Next Bull Market
10:23am, Tuesday, 04'th Apr 2023
Catalyst Pharmaceuticals expects improving results this year. Its new epilepsy medicine is likely to see continued healthy growth.
